FO
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients |  | 2020 | 637 | 0 | |||
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases |  | 2020 | 462 | 135 | ||
| Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patients | Open Forum Infectious Diseases | | 2019 | 302 | 249 | ||
| A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial | Clinical microbiology and infection | | 2019 | 228 | 246 | ||
| Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective | Clinical Microbiology and Infection | | 2017 | 595 | 400 | ||
| Clonal or not clonal? Investigating hospital outbreaks of KPC-producing Klebsiella pneumoniae with whole-genome sequencing | Clinical Microbiology and Infection |  | 2017 | 533 | 1 | ||
| Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014 | Schweizerische medizinische Wochenschrift | | 2016 | 537 | 0 | ||
| Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection | The journal of antimicrobial chemotherapy | | 2015 | 638 | 0 | ||
| Compliance with antibiotic prophylaxis guidelines in a university hospital’s neurosurgical unit : a 7-year follow-up | 3rd International Conference on Prevention and Infection Control (ICPIC 2015) | | 2015 | 23 | 16 |
